Clinical Trials Browser

OTHER × AZD 6244 × Gastrointestinal × Clear all

NCT02151084 2025-12-16

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

Phase 2 Active not recruiting

Gastrointestinal

Gallbladder Neoplasms, Recurrence

NCT01160926 2023-04-24

DREAMtherapy

Phase 1 Terminated

Gastrointestinal

Rectal Neoplasms

NCT01242605 2016-05-13

ABC-04

Phase 1 Completed

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT01029418 2015-04-16

AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms